CG
TRML

Carmignac Gestion’s Tourmaline Bio TRML Stock Holding History

Carmignac Gestion’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55,412
Closed -$2.65M – 164
2025
Q3 		$2.65M Buy
+55,412
New +$1.54M 0.04% 94

Carmignac Gestion's TRML Position: Q4 2025 in Review

Carmignac Gestion sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 55,412 shares — an estimated $2.65M sold.

Carmignac Gestion first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $2.65M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Carmignac Gestion reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Carmignac Gestion sold 55,412 Tourmaline Bio shares in Q4 2025, an estimated $2.65M.
  • Carmignac Gestion first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Carmignac Gestion's Tourmaline Bio position peaked at $2.65M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Carmignac Gestion's 13F filing for Q4 2025, filed 13 Feb 2026.